Chayan Acharya, Ph.D.

Senior Consultant

Portrait-of-Chayan-Acharya_Pharmetheus

Bio

  • Joined Pharmetheus in 2015, actively working in client projects, with continuous improvements, and training Pharmetheus colleagues in R
  • Expertise includes model informed drug development, non-compartmental analysis, and pharmacometrics in therapeutic areas such as immunology, inflammation and analgesia
  • Previously worked as Postdoctoral Researcher at Uppsala University, Sweden, where he developed an R-package for population pharmacokinetic model diagnosis using non-compartmental analysis metrics, and as Postdoctoral Fellow at University of California San Diego, USA and University of Bordeaux 1, France, with molecular force field development and structure/ligand-based drug design
  • M.Sc. in Physics (2003) from the Indian Institute of Technology Bombay, India, and Ph.D. in Pharmaceutical Sciences (2009) from University of Maryland Baltimore, USA
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Use of informative prior distributions from mepolizumab data to support depemokimab PKPD model analysisPopulation PK analysis of Pegaspargase in Japanese and non-Japanese patients with acute lymphoblastic leukemiaPopulation Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use DisorderPopulation Pharmacokinetics and Exposure-Response for Dapirolizumab Pegol From a Phase 2b Trial in Patients With Systemic Lupus ErythematosusPopulation Pharmacokinetic and Exposure-Response Models for Dapirolizumab Pegol in Patients with Systemic Lupus ErythematosusModel Based Support to Biosimilarity Assessment Planning – A Case Study of PegfilgrastimA Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim